Q3 2021 OpGen Inc Earnings Call Transcript
Welcome to the OpGen Third Quarter 2021 Earnings Call and Business Update. (Operator Instructions) As a reminder, this conference call is being recorded today, November 11, 2021.
Before we begin, I would like to caution you that any comments made during this conference call by management may contain forward-looking statements regarding the operations of, and future results of OpGen, including its subsidiaries, Curetis and Ares Genetics. I encourage you to review OpGen's filings with the Securities and Exchange Commission, including without limitation, the company's most recent Form 10-K and Form 10-Q for the third quarter of 2021 that will be filed with the SEC, which will identify specific factors that may cause actual results or events to differ materially from those described in the forward-looking statements.
Factors that may affect the company's results include, but are not limited to, our ability to successfully achieve the expected synergies from the company's completed business combination with Curetis and to implement our commercial strategy, the impact of the continuing global
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |